ESR2 and breast carcinoma: For instance, in breast cancer, it has been demonstrated that CDK12 activates the Erb-PI3-AKT or WNT/β-catenin signalling pathways by phosphorylating RNA Pol II, thereby contributing to cancer cell initiation, invasion, and sustained self-renewal3.